These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7705689)
1. Peritoneal papillary serous carcinoma arising in an infertile woman during ovulation-induction therapy: immunohistochemical expression of LH/hCG receptors. Komatsu T; Konishi I; Mandai M; Koshiyama M; Nanbu K; Yamamoto S; Kanzaki H; Rao CV; Mori T Gynecol Oncol; 1995 Mar; 56(3):470-4. PubMed ID: 7705689 [TBL] [Abstract][Full Text] [Related]
2. Rapid growth of an ovarian clear cell carcinoma expressing LH/hCG receptor arising from endometriosis during early pregnancy. Kobayashi F; Monma C; Nanbu K; Konishi I; Sagawa N; Mori T Gynecol Oncol; 1996 Aug; 62(2):309-13. PubMed ID: 8751567 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful. Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993 [TBL] [Abstract][Full Text] [Related]
4. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case. Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708 [TBL] [Abstract][Full Text] [Related]
5. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma. Killackey MA; Davis AR Gynecol Oncol; 1993 Nov; 51(2):171-4. PubMed ID: 8276289 [TBL] [Abstract][Full Text] [Related]
6. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Comin CE; Saieva C; Messerini L Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535 [TBL] [Abstract][Full Text] [Related]
7. [Serous peritoneal papillary tumor of low malignancy potential. Report of a case]. Mayerson D; Rondini C; Braun H; Chuaqui R; Brañes J Rev Med Chil; 2000 Feb; 128(2):206-10. PubMed ID: 10962890 [TBL] [Abstract][Full Text] [Related]
8. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors. Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882 [TBL] [Abstract][Full Text] [Related]
9. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas. Ordóñez NG Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268 [TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer after successful ovulation induction: a case report. Hull ME; Kriner M; Schneider E; Maiman M J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076 [TBL] [Abstract][Full Text] [Related]
11. [Peritoneal papillary serous carcinoma: clinical report]. Stagnitti F; Mongardini M; Schillaci F; Scirocchi R; De Petris L; Malizia A; Marenga G; Patrizi V; Priore FM; Corona F; Tiberi R; Di Placido M; Calderisi MD; Longo F G Chir; 2002 Oct; 23(10):379-82. PubMed ID: 12611260 [TBL] [Abstract][Full Text] [Related]
12. [Extraovarian peritoneal serous papillary carcinoma: studies of clinical and pathological features]. Shi X; Guo Y; Li J Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):711-3. PubMed ID: 9387509 [TBL] [Abstract][Full Text] [Related]
13. Primary malignant mesothelioma of the peritoneum: a clinical and immunohistochemical study. Markaki S; Protopapas A; Milingos S; Lazaris D; Antsaklis A; Michalas S Gynecol Oncol; 2005 Mar; 96(3):860-4. PubMed ID: 15721439 [TBL] [Abstract][Full Text] [Related]
14. [Serous papillary cystadenocarcinoma of the recto-vaginal septum: a rare primary localization]. Leteurtre E; Boman F; Farine MO; Querleu D; Gosselin B Ann Pathol; 1999 Mar; 19(1):42-5. PubMed ID: 10320912 [TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Schorge JO; Miller YB; Qi LJ; Muto MG; Welch WR; Berkowitz RS; Mok SC Gynecol Oncol; 2000 Mar; 76(3):369-72. PubMed ID: 10684712 [TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
17. Peritoneal papillary serous cystadenocarcinoma at a previous laparoscopic trocar site. Wang LM; Jeng CJ; Lin SE; Shen J Taiwan J Obstet Gynecol; 2012 Sep; 51(3):463-4. PubMed ID: 23040941 [No Abstract] [Full Text] [Related]
18. Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum. Skates S; Troiano R; Knapp RC Int J Gynecol Cancer; 2003; 13(5):693-6. PubMed ID: 14675358 [TBL] [Abstract][Full Text] [Related]
19. [Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells]. Novichkov EV; Votintsev AA Arkh Patol; 2006; 68(2):10-3. PubMed ID: 16752501 [TBL] [Abstract][Full Text] [Related]
20. Papillary cystadenocarcinoma arising in a paratubal mesothelial cyst of the mesosalpinx--a case report. Narurkar SD; Buch AC; Patel KD; Avasare SS; Niyogi GM Indian J Cancer; 2001; 38(2-4):137-42. PubMed ID: 12593453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]